Last checked at 
Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Like last year, posts no revenue in six months to June 30. Pretax loss widens to EUR2.0 million from EUR439,000. Posts EUR1.1 million in other losses, compared to gains to EUR463,000 a year earlier.
Current stock price: 14.00 pence
Year-to-date change: up 19%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.